Clinical Trial Update: Evaluating the Clinical Efficacy and Safety of Luspatercept Combined With Thalidomide in the Treatment of β-TDT Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of luspatercept in combination with thalidomide for transfusion-dependent beta-thalassemia (β-TDT) i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• Luspatercept (luspatercept)
• Thalidomide (thalidomide)

Snippet

Sponsor: Rongrong Liu | Conditions: Transfusion-dependent β-thalassemia Patients | Phase 2 | Status: RECRUITING